|
|
|
¾ç±ÝÀÚ ( Yang Geum-Ja ) - ºÎ»ê´ëÇб³º´¿ø
°Á¤Èñ ( Kang Jeong-Hee ) - ÀüºÏ´ëÇб³ °£È£´ëÇÐ ¼Àμ± ( Suh In-Sun ) - ÀüºÏ´ëÇб³ °£È£´ëÇÐ ±èÇý¿µ ( Kim Hye-Young ) - ÀüºÏ´ëÇб³ °£È£´ëÇÐ
|
|
Abstract
|
|
|
|
Purpose: The aim of this study was to compare the health-related quality of life (HQOL) and depression in prostate cancer patients with radial prostatectomy or hormonal therapy more than 6 months ago.
Methods: A total of 116 patients participated in the study (83 radical prostatectomy patients and 33 hormonal therapy). Data were collected from 13th September to 13th November 2012, using two instruments-translated into Korean: Expanded Prostate Cancer Index Composite and Geriatric Depression Scale Short Form.
Results: Hormonal therapy participants reported significantly higher scores of HQOL than radical prostatectomy participants did (p=.002). The HQOL subscales with significant differences were urinary function (p<.001) and incontinence (p<.001) under urinary domain and sexual bother (p<.001) under sexual domain. The level of depression was not significantly different between the two treatment groups. There were moderate negative correlations between HQOL and depression in both groups.
Conclusion: Many of prostate cancer patients reported treatment-related functional deteriorations in urinary and sexual domains and they were depressed even more than 6 months after the treatment completion. To manage prostate cancer patients¡¯ HQOL and depression, clinicians including nurses should evaluate patients¡¯ complaints according to their treatment modality and intervene accordingly.
|
|
KeyWords
|
|
Àü¸³¼±¾Ï, »îÀÇ Áú, ¿ì¿ï, Àü¸³¼±ÀýÁ¦¼ú, È£¸£¸ó¿ä¹ý
Prostatic Neoplasms, Quality of Life, Depression, Prostatectomy, Hormone Replacement
|
|
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
|
|
|
|
µîÀçÀú³Î Á¤º¸
|
|
|
|
|
|